[go: up one dir, main page]

BRPI0417263A - imidazopiridinas para uso como inibidores de secreção gástrica - Google Patents

imidazopiridinas para uso como inibidores de secreção gástrica

Info

Publication number
BRPI0417263A
BRPI0417263A BRPI0417263-9A BRPI0417263A BRPI0417263A BR PI0417263 A BRPI0417263 A BR PI0417263A BR PI0417263 A BRPI0417263 A BR PI0417263A BR PI0417263 A BRPI0417263 A BR PI0417263A
Authority
BR
Brazil
Prior art keywords
imidazopyridines
gastric secretion
secretion inhibitors
inhibitors
gastric
Prior art date
Application number
BRPI0417263-9A
Other languages
English (en)
Inventor
Wilm Buhr
M Vittoria Chiesa
Peter Jan Zimmermann
Christof Brehm
Wolfgang-Alexander Simon
Wolfgang Kromer
Stefan Postius
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of BRPI0417263A publication Critical patent/BRPI0417263A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"IMIDAZOPIRIDINAS PARA USO COMO INIBIDORES DE SECREçãO GáSTRICA". A invenção fornece compostos da fórmula 1, em que os substituintes e símbolos são como definido na descrição. Os compostos inibem a secreção de ácido gástrico.
BRPI0417263-9A 2003-12-19 2004-12-17 imidazopiridinas para uso como inibidores de secreção gástrica BRPI0417263A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03029361 2003-12-19
PCT/EP2004/053560 WO2005058325A1 (en) 2003-12-19 2004-12-17 Tricyclic imidazopyridines for use as gastric secretion inhibitors

Publications (1)

Publication Number Publication Date
BRPI0417263A true BRPI0417263A (pt) 2007-03-06

Family

ID=34684549

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417263-9A BRPI0417263A (pt) 2003-12-19 2004-12-17 imidazopiridinas para uso como inibidores de secreção gástrica

Country Status (15)

Country Link
US (1) US20070066674A1 (pt)
EP (1) EP1696921A1 (pt)
JP (1) JP2007514714A (pt)
KR (1) KR20070007041A (pt)
CN (1) CN1889955A (pt)
AR (1) AR046941A1 (pt)
AU (1) AU2004298788A1 (pt)
BR (1) BRPI0417263A (pt)
CA (1) CA2549030A1 (pt)
EA (1) EA200601106A1 (pt)
IL (1) IL175724A0 (pt)
NO (1) NO20063220L (pt)
TW (1) TW200526212A (pt)
WO (1) WO2005058325A1 (pt)
ZA (1) ZA200604134B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1697358A1 (en) 2003-12-19 2006-09-06 Altana Pharma AG Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
TW200726752A (en) * 2005-06-22 2007-07-16 Altana Pharma Ag Process for the production of intermediates for the preparation of tricyclic benzimidazoles
WO2007141253A1 (en) * 2006-06-07 2007-12-13 Nycomed Gmbh Process for the production of intermediates for the preparation of tricyclic imidazopyridines
WO2011004882A1 (ja) 2009-07-09 2011-01-13 ラクオリア創薬株式会社 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
WO2014195333A1 (de) 2013-06-04 2014-12-11 Bayer Pharma Aktiengesellschaft 3-aryl-substituierte imidazo[1,2-a]pyridine und ihre verwendung
JP2017507140A (ja) 2014-02-19 2017-03-16 バイエル・ファルマ・アクティエンゲゼルシャフト ３−（ピリミジン−２−イル）イミダゾ［１，２−ａ］ピリジン
CN107001361A (zh) 2014-12-02 2017-08-01 拜耳医药股份有限公司 杂芳基取代的咪唑并[1，2‑a]吡啶及其用途
CN112500421B (zh) * 2020-12-15 2021-08-24 河南科技大学第一附属医院 一种可用于杀菌消毒的苯并吡喃脲类化合物的制备方法及应用
CN115754084B (zh) * 2022-11-30 2024-07-12 天和药业有限公司 一种吗伐考昔的分析方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
CA2426616A1 (en) * 2000-10-25 2002-05-02 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
WO2003014123A1 (en) * 2001-08-10 2003-02-20 Altana Pharma Ag Tricyclic imidazopyridines

Also Published As

Publication number Publication date
CA2549030A1 (en) 2005-06-30
NO20063220L (no) 2006-07-11
EA200601106A1 (ru) 2006-12-29
KR20070007041A (ko) 2007-01-12
JP2007514714A (ja) 2007-06-07
IL175724A0 (en) 2006-09-05
AR046941A1 (es) 2006-01-04
ZA200604134B (en) 2008-01-30
WO2005058325A8 (en) 2006-05-11
WO2005058325A1 (en) 2005-06-30
AU2004298788A1 (en) 2005-06-30
TW200526212A (en) 2005-08-16
US20070066674A1 (en) 2007-03-22
CN1889955A (zh) 2007-01-03
EP1696921A1 (en) 2006-09-06

Similar Documents

Publication Publication Date Title
NO20044995L (no) Heterosykliske forbindelser
UY29479A1 (es) Inhibidores de adn-pk
BRPI0514125A (pt) piridinas condensadas como inibidores de cinase
GB0100889D0 (en) Compounds
BR0313330A (pt) Piperidina-ftalazonas substituìdas com pirrolidinadiona como inibidores de pde4
DK1483265T3 (da) Purinderivater som kinaseinhibitorer
DE60334536D1 (de) Furylverbindungen
NO20061317L (no) Imidazopyridinderivater som induserbare NO-syntaseinhibatorer
DE60333746D1 (de) Thienylverbindungen
BRPI0411897A (pt) pirroldihidroisoquinolinas como inibidores de pde10
BR0207278A (pt) Derivados de ftalazinona-piperidina como inibidores de pde4
BRPI0606379A2 (pt) triazolftalazinas
WO2007120333A3 (en) Tetracyclic kinase inhibitors
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
BR0109542A (pt) Derivados de imidazopirina alquilados
SE0103710D0 (sv) Compounds
DE60204701D1 (de) Tricyclische imidazopyridine
NO20081292L (no) Pentasykliske kinaseinhibitorer
NO20063220L (no) Tricykliske imidazopyridiner for anvendelse som gastriske sekresjonsinhibitorer
NO20061316L (no) Imidazopyndinderivater som induserbare NO-syntaseinhibitorer
NO20061344L (no) Imidazopyridinderivater som induserbare NO-syntaseoinhibitorer
SE0403085D0 (sv) Novel componds
SE0403086D0 (sv) Compounds
NO20080144L (no) Spiro-benzimidazoler som inhibitorer av magesyre og sekresjon
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.